Join the 'Focal Segmental Glomerulosclerosis' group to help and get support from people like you.
Focal Segmental Glomerulosclerosis News
Posted 8 Nov 2013 by Drugs.com
FRIDAY, Nov. 8 – A drug that is currently prescribed for rheumatoid arthritis also may be beneficial for patients with a common form of kidney disease that is difficult to treat and often leads to kidney failure, according to a small new study. Researchers said they also identified a way to help determine which patients would be most likely to benefit from the drug. The condition, called focal segmental glomerulosclerosis (FSGS), causes scar tissue to form in the kidneys' filtering units. Most people affected by the disease are also obese or have high blood pressure or diabetes. Although steroids and certain drugs that suppress the immune system help some people with FSGS, these treatments have long-term side effects that may outweigh the drug's benefits, the researchers said. "We identified abatacept as the first personalized, targeted treatment for kidney disease and specifically for ... Read more